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Introduction: Atypical presentations in hepatitis A virus (HAV) infection are 
uncommonly encountered; nevertheless, they may lead to serious clinical 
complications. The present study reported the frequency of atypical 
presentations among children with acute HAV infection in south-east of Iran.  
Materials and Methods: This prospective (cohort) study was conducted in the 
gastroenterology clinic of Amir-Al-Momenin Hospital (Zabol, Sistan and 
Baluchestan province, Iran). A total of 294 children with positive anti-HAV 
IgM test were enrolled during 2015-2018. They were prospectively monitored 
for the incidence of any atypical presentation.  
Results: Out of 294 children, 152 (51.7%) were males, and the mean age was 
7.3±3.5. Nausea and vomiting (41.8%) constituted the most frequent clinical 
presentations. Overall, atypical presentations were observed in 38 (12.8%). The 
atypical presentations included autoimmune hepatitis (AIH) (15, 5.1%), 
pancytopenia (11, 3.7%), non-immune hemolytic anemia (5, 1.7%), Wilson 
disease (3, 1%), prolonged cholestasis (3, 1%), and gallbladder hydrops (1, 
0.3%). The mean level of alanine aminotransferase at diagnosis was 
significantly lower in patients with atypical presentations compared with those 
without such complications (801.28±986.61 vs. 1119.09±1109.98 IU/l, 
P=0.01). Patients with atypical manifestations also had significantly lower 
levels of total bilirubin (3.77±2.88 vs. 5.57±5.28 mg/dl, P=0.03) and direct 
bilirubin (2.03±2.06 vs. 2.91±3.20 mg/dl, P=0.04).  
Conclusion: Atypical manifestations are relatively common among children 
with acute HAV infection and should be routinely screened. With timely and 
appropriate interventions, clinical outcomes may not be significantly different 
from patients with typical presentation.  
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1. Introduction 
     Hepatitis A virus (HAV) is the etiology 
for a common viral infection affecting 
several people worldwide. HAV contains a 
single-strand RNA as its genetic material 
and is transmitted through oral routes. The 
clinical presentation of HAV infection 
ranges from asymptomatic to abrupt 
jaundice and hepatitis or chronic 
presentation with atypical complications. 
Young children usually follow an 
asymptomatic and self-limiting pattern 
while adults usually manifest jaundice of 
variable severities and durations. Fatigue, 
nausea, and dark urine are other common 
clinical presentations in acute HAV 
infection [1]. Although HAV infection is 
commonly recognized as an acute infectious 
disease, chronic illness may be observed in 
a ratio of patients. In patients with chronic 
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HAV infection, long-term atypical 
presentations are the most troublesome 
issue requiring prompt considerations [2].  
The most serious long-term atypical 
complications of HAV have been 
recurrence of the disease, fulminant 
hepatitis, autoimmune hepatitis (AIH), 
cholestasis, hemolytic and plastic anemias, 
acute kidney failure, pericardial effusion, 
arthritis, and pancreatitis [3, 4]. AIH is a 
chronic liver disease characterized by the 
development of autoantibodies, 
hypergammaglobulinemia, and interface 
hepatitis in histological examination. Viral 
hepatitis can be a triggering factor for AIH 
in individuals with appropriate genetic 
signatures [5]. The overall prevalence of 
atypical manifestations in HAV infection 
has been reported as 7-14% [4, 6]; however, 
the incidence is variable based on the nature 
of the complication.  
Our knowledge on atypical manifestations 
of HAV infection is merely limited to cases 
reports, and particularly, to few studies 
which have addressed the incidence of these 
complications among children both 
worldwide, and in Iran [4]. This lack of 
information can lead to inappropriate, 
unnecessary and often detrimental 
treatments in these patients. Therefore, this 
study aimed to address the incidence of 
atypical clinical presentations associated 
with acute HAV infection in children.  
 
2. Materials and Methods 
2.1 Patients  
     A total of 294 children appearing with 
acute HAV were prospectively (cohort) 
followed up. The patients were admitted to 
the gastroenterology clinic of Amir-Al-
Momenin Hospital of Zabol, Iran during 
2015-2018.  
 
2.2 Inclusion and Exclusion Criteria  
     Inclusion criteria were having icter and a 
positive result for anti-HAV IgM antibody 
test. Those children whose parents did not 
agree to participate were excluded. Also, 
the patients with evidences of other viral 
hepatitis infections (i.e. HBV, and HCV) 
were excluded.  
 
2.3 Atypical Outcomes  
     The patients were prospectively watched 
over during a six-month period for the 
occurrence of any atypical presentation. 
These included AIH, pancytopenia 
(characterized with peripheral blood 
leukopenia, reticulocytopenia, and 
thrombocytopenia), Wilson disease (an 
inherited disease characterized with copper 
accumulation in the body organs, 
particularly liver), cholestasis (the 
obstruction of bile flow), gallstones, and 
hemolytic anemia.  
 
2.4 Biochemical Parameters  
     After being diagnosed with acute HAV, 
blood samples were taken (10 ml) for 
determining hematological and biochemical 
parameters. Blood cell counts including 
white blood cell (WBC), red blood cell 
(RBC) and platelet count, as well as 
hemoglobin were recorded. Liver enzymes, 
namely alanine and aspartate 
aminotransferases (AST and ALT) were 
assessed both at the diagnosis and six 
months afterwards. Total and direct 
bilirubin, albumin, and total protein were 
also measured.  
 
2.5 Statistical Analysis  
     The data was presented using descriptive 
statistics (SPSS 16). After checking for 
normality by Shapiro-Wilk test, Mann 
Whitney U test and independent samples 
student t-test were used to compare the 
intended variables between patients with 
typical and atypical presentations. For 
multiple group comparisons, either one-way 
ANOVA (parametric) or Kruskal-Wallis 
(non-parametric) test was used based on the 
distribution of the data. P<0.05 was 
assigned as the statistical significance level.  
 
Ethical Approval   
This study was conducted according to the 
Helsinki declaration (2013) and was 
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approved by the Ethics Committee of Zabol 
University of Medical Sciences (ethical 
code: Zbmu.1.REC.1396.65).   
 
Informed Consent 
The aim of the study was explained to the 
parents at first appointment, and informed 
consent was obtained from them. 
3. Results 
     Out of 294 children, 152 (51.7%) were 
males and 142 (48.3%) were females. The 
mean age of the patients was 7.3±3.5 years 
(table 1). Nausea and vomiting (41.8%) 
constituted the most frequent clinical 
presentations (table 2). 
 
Table 1. Clinical features of 294 children with acute hepatitis A infection 
Parameters Minimum Maximum Mean Std. Deviation 
Age (years) 0.5 27 7.3 3.5 
Aspartate amino transferase  
(diagnosis) (IU/l) 
24 5330 935.4 1069.1 
Aspartate amino transferase  
(six months) (IU/l) 
11 59 21.3 6.7 
Alanine amino transferase  
(diagnosis) (IU/l) 
16 5331 1121.5 1048.7 
Alanine amino transferase  
(six months) (IU/l) 
7.8 65 16.2 5.3 
White blood cell count (ul) 2800 38000 7695.4 3326.1 
Hemoglobin (g/dl) 7.1 19.2 11.9 1.5 
Platelet (10
3
/ul) 4.2 821 344.2 122.5 
Albumin (g/dl) 3 8.1 4.4 0.8 
Total Bilirubin (mg/dl) 0.1 22.4 4.6 4.2 
Direct Bilirubin (mg/dl) 0.1 23.8 2.4 3.1 
Total Protein (g/dl) 4 9.8 6.9 0.9 
 
Table 2. Clinical presentation of 294 children with acute hepatitis A infection 
Symptoms n (%) 
Nausea and vomiting  123 (41.8) 
Dark urine 58 (19.7) 
White stool 44 (14.9) 
Icter 126 (42.8) 
fever 101 (34.3) 
Abdominal pain  89 (30.2) 
Nil per os (NPO) intolerance 19 (6.4) 
Itching  12 (4) 
Coriza 14 (4.7) 
Headache  6 (2) 
Cough 4 (1.3) 
diarrhea 8 (2.7) 
Loss of appetite 29 (9.8) 
 
The atypical presentations included AIH 
(15, 5.1%), pancytopenia (11, 3.7%), non-
immune hemolytic anemia (5, 1.7%), 
Wilson disease (3, 1%), prolonged 
cholestasis (3, 1%), and gallbladder hydrops 
(1, 0.3%). There were no statistically 
significant differences comparing the mean 
age of patients with (10.2±11 years) and 
without (7.53±4.34 years) atypical 
presentations (P=0.63). The mean level of 
ALT at diagnosis was significantly lower in 
patients with atypical presentations 
compared with those without such 
complications (801.28±986.61 vs. 
1119.09±1109.98 IU/l, P=0.01). Patients 
with atypical manifestations also had 
significantly lower baseline levels of total 
bilirubin (3.77±2.88 vs. 5.57±5.28 mg/dl, 
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P=0.03) and direct bilirubin (2.03±2.06 vs. 
2.91±3.20 mg/dl, P=0.04). Regarding other 
variables, no significant differences were 
observed between those with or without 
atypical presentations (Table 3). 
Table 4 describes the mean values of age 
and biochemical and hematological 
variables in groups of patients with each 
specific atypical presentation. The levels of 
AST, ALT, as well as WBC and platelet 
count significantly differed among patients 
with different HAV-associated atypical 
manifestations. Other variables showed no 
statistically significant differences among 
these groups.  
 
Table 3. Comparison of laboratory parameters between HAV-infected children with or without atypical presentations 




P value  
Age (years) 10.23±11 7.53±4.34 0.63 
AST (IU/l) 687.69±841.29 881.12±1016.1 0.15* 
ALT (IU/l) 801.28±986.61 1119.09±1109.98 0.01* 
Albumin (g/dl) 4.28±0.98 4.37±0.84 0.68 
Total protein (g/dl) 7.52±1.29 7.60±1.77 0.81 
Total bilirubin (mg/dl) 3.77±2.88 5.57±5.28 0.03* 
Direct bilirubin (mg/dl) 2.03±2.06 2.91±3.20 0.04* 
WBC (10
3
/ul) 6.69±3.96 7.65±3.29 0.14 
Hemoglobin (g/dl) 11.4±2.46 11.87±1.78 0.20 
Platelet (10
3
/ul) 263.37±182.96 313.21±150.36 0.09 
 *; Mann-Whitney U test. Abbreviations: AST; aspartate aminotransferase, ALT; alanine aminotransferase, WBC; white 
blood cell count. 
 
Table 4. Laboratory parameters in children with acute HAV infection with typical and atypical presentations  
 
*; Kruskal-Wallis test. †; Abbreviation: IBD: inflammatory bowel disease, AIH; autoimmune hepatitis, NIHA; non-
immune hemolytic anemia, WD; Wilson disease, AST; aspartate aminotransferase, ALT; alanine aminotransferase, 
WBC; white blood cell count, Alb; albumin, TB; total bilirubin, DB; direct bilirubin, TP; total protein 
 
The patients with cholestasis were 
successfully managed by the administration 
of UDCA (15 mg/kg/day). The patients with 
AIH were managed by prednisolone (2 
mg/kg) daily. Those with Wilson disease 
were administrated with penicillamine. The 
patients with hemolytic anemia and 
pancytopenia were also managed by 
transfusion of blood products. These 
patients recovered spontaneously and did 
not require immunosuppressive therapies. 
There were no deaths or disease recurrences 













Age (years) 7.4 ± 4.3 12.6 ± 4.4 6.5± 3.5 5.4±3.9 3.8±2 10.3±5 0.056 
AST (IU/l) 880.7 ± 1010.5 623.05 ± 856.1 1365.9±10002.8 566.8 ±484.1 370.6±254.2 232 ±126.4 0.06* 
ALT (IU/l) 1115.7±1104.3 760.9±1044.3 1365±1110.2 864.8±892.2 463.3±156.8 271.6±183.1 0.06* 
WBC (10
3
/ul) 7.6±3.2 7.3±3.7 2.6±1.1 6.4±3.1 7.7±1.3 6.4±4.9 0.001 
Hemoglobin (g/dl) 11.8±1.7 11.8±2.7 9.3±0.8 10.8±1.5 11.3±0.8 12.2±3.2 0.056 
Platelet (10
3
/ul) 314.5±149.8 306±168.2 49.8±23 225.5±163.6 429.5±334.4 331.5±283.5 0.001 
Alb (g/dl) 4.3±0.8 4.2±0.6 4.4±0.5 3.9±0.2 3.51.2 3.8±0.7 0.28 
TB (mg/dl) 5.6±5.2 3.4±2.7 3.7±2.2 4.3±2.1 6.4±2.3 1.3±0.7 0.38 
DB (mg/dl) 2.9±3.1 2±1.9 2.9±2.2 2.7±3.7 3.2±2.4 0.5±0.4 0.81 
TP (g/dl) 7.5 ±1.7 7.7±1 6.3±3.2 9.3±0.2 5.6±4.9 6.4±0.7 0.16 
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     Atypical presentations in patients with 
acute HAV infection may deviate the 
clinical course of this infection from a 
benign self-limiting disease to a life-
threatening situation. In the present study, 
the incidence of atypical complications in 
acute HAV infection was screened among 
294 children. The observed atypical 
presentations included AIH (5.1%), 
pancytopenia (3.7%), hemolysis (1.7%), 
Wilson disease (1%), cholestasis (1%) and 
hydrops (0.3%). The mean level of ALT at 
diagnosis was significantly lower in patients 
with atypical presentations compared with 
those without such complications 
(801.28±986.61 vs. 1119.09±1109.98 IU/l, 
P=0.01). Patients  with atypical 
manifestations also had significantly lower 
levels of total bilirubin (3.77±2.88 vs. 
5.57±5.28 mg/dl, P=0.03) and direct 
bilirubin (2.03±2.06 vs. 2.91±3.20 mg/dl, 
P=0.04) at diagnosis. However, no 
significant differences were observed 
between those with or without atypical 
presentations regarding age and baseline 
levels of AST, albumin, total protein, WBC, 
hemoglobin, and platelet count.  
AIH has been reported alongside with HAV 
infection merely as case reports [7-14]. The 
development of AIH over HAV course may 
result in persistent positivity for anti-HAV 
IgM antibodies even after 18 months to four 
years following the diagnosis [11, 15]. In a 
mutual interaction, it has been noted that 
HAV infection itself may trigger 
autoimmunity against hepatocytes [7, 11, 
16-18]. In fact, HAV and AIH may be 
indifferentiable during initial phases [19], 
and chronic HAV infections are suggested 
to be further scrutinized for the evidences of 
AIH [15]. Persistent elevated liver enzymes 
following treatment of HAV infection may 
indicate the development of AIH [9]. If left 
untreated or undiagnosed, AIH may 
progress to liver failure, and therefore, the 
identification of concurrent AIH in the 
context of acute viral hepatitis is of crucial 
importance [2].  
In the present study, 3 out of 294 children 
with acute HAV infection were diagnosed 
with Wilson disease during the course of the 
disease. The diagnosis of Wilson disease 
may be difficult from AIH in the context of 
viral hepatitis [20]. However, in the present 
study, patients with Wilson disease did not 
show any significant difference in 
laboratory findings at presentations. Wilson 
disease is a rare congenital defect of copper 
transportation and is associated with direct 
cytotoxicity to hepatocytes due to copper 
overload [21]. Furthermore, 11 of our 
patients developed pancytopenia. 
Pancytopenia is among relatively common 
hematologic manifestations of HAV 
infection. Pancytopenia in children with 
acute hepatitis is usually transient requiring 
no serious intervention [22]. In the 11 
patients identified in our study, all were 
recovered spontaneously and were managed 
by transfusion of blood products. 
Nevertheless, this condition also may be 
progressive leading to even death secondary 
to comorbidities [23]. Pancytopenia is 
usually a part of hepatitis-associated 
aplastic anemia which may be seen several 
weeks after hepatitis diagnosis [24-26]. The 
pathogenesis is supposed to be related to 
immune dysregulation triggered by the virus 
[27]. Other causes of pancytopenia in 
patients with acute viral hepatis may be 
intensive splenomegaly [28] and 
hemophagocytic syndrome [29].  
In the present study, non-immune hemolytic 
anemia was observed in 5 out of 294 
patients. Although hemolysis is a relatively 
common atypical presentation in acute 
HAV infection [30] and other viral causes 
of hepatitis [31, 32], but this has been 
associated with autoimmune hemolytic 
anemia as evidenced by several case reports 
in this context [8, 33-35]. This phenomenon 
has been further suggested to be associated 
with AIH [31, 36]. Neither of our patients 
represented positive coombs tests which 
  Hepatitis A atypical presentations in children, Shahramian N et al.      
 
 Archives of Advances in Biosciences is an open access article under the terms of the Creative Commons Attribution -NonCommercial 4.0 International License,  
61 
ruled out the autoimmune nature of the 
hemolysis. Instead, schistocytes along with 
thrombocytopenia were seen in peripheral 
blood smear reviews indicating a possible 
microangiopathic hemolytic anemia.  
Cholestasis may be encountered in some 
children with acute HAV infection [37], 
which may prolong hospital stay [38]. 
Cholestatic hepatitis has been reported in 
2.5-6.1% of HAV-infected children [6, 39]. 
Among adults with acute HAV infection, 
cholestasis was noted as 2-6.8% [1, 40-42]. 
The administration of herbal drugs has been 
noted as a risk factor for cholestasis in 
children with HAV infection [43]. Other 
risk factors have been noted as concurrent 
Dubin-Johnson syndrome [44], INR >1.5 
[42], and concomitant HBV infection [41, 
45]. Cholestasis may also indicate a relapse 
of HAV infection [33], therefore, these 
patients should be carefully watched.  
From limitations of this study was the low 
number of patients with some specific 
atypical presentations such as Wilson 
disease and cholestasis (each with n=3), and 
hemolytic anemia (n=5), which limited the 
power of study. Besides HBV and HCV, we 
did not test for other viral causes of 
hepatitis; however, because very low 
frequencies of these types in our region, and 
in clinical examinations, we tried to rule out 
any other underlying hepatic diseases. 
Researchers are suggested to assess the 
incidence and clinical course of these 
atypical manifestations in other populations.   
 
5. Conclusion 
     Atypical manifestations are relatively 
common among children with acute HAV 
infection. Pediatricians should be aware of 
these complications and take appropriate 
diagnostic and therapeutic measures. 
Although some presentations such as 
pancytopenia and hemolytic anemia may be 
resolved spontaneously, attention ought to 
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